ScholarIQanswers from OpenAlex
Parvovirus B19 Infection Studies
TopicLeading institutions, researchers & key papers
Parvovirus B19 Infection Studies is a topic indexed in ScholarIQ from OpenAlex.
What is known about Parvovirus B19 Infection Studies?
ScholarIQrecord summary
This cluster of papers focuses on the infection, pathogenesis, and clinical implications of Parvovirus B19, particularly in the context of fetal hydrops, autoimmune diseases, and pregnancy complications. It also explores viral transmission, persistence in immunocompetent and immunocompromised individuals, and the association with various hematological and rheumatic disorders.
How many works does Parvovirus B19 Infection Studies have?
ScholarIQindexed works
Parvovirus B19 Infection Studies has 115 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Parvovirus B19 Infection Studies?
ScholarIQopenalex
The OpenAlex for Parvovirus B19 Infection Studies is on the source record.
What are the most-cited papers on Parvovirus B19 Infection Studies?
ScholarIQmost cited works
Iron (III) induces aggregation of hyperphosphorylated τ and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease
Akira Yamamoto, Ryong‐Woon Shin, Kazuhiro Hasegawa, Hironobu Naiki, Hiroyuki Sato, F Yoshimasu, Tetsuyuki Kitamoto
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case–control study nested in a cohort of Norwegian blood donors
K T Jørgensen, Allan Wiik, Maria Pedersen, Chris Juul Hedegaard, Bent Faber Vestergaard, Randi E. Gislefoss, Tore K Kvien, Jan Wohlfahrt, Klaus Bendtzen, Morten Frisch
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
Stefania Paolucci, Irene Cassaniti, Federica Novazzi, L Fiorina, Antonio Piralla, Giuditta Comolli, Raffaele Bruno, Renato Maserati, Roberto Gulminetti, Stefano Novati, Francesco Mojoli, Fausto Baldanti, Raffaele Bruno, Mario U. Mondelli, Enrico Brunetti, Angela Di Matteo, Elena Seminari, Laura Maiocchi, Valentina Zuccaro, Layla Pagnucco, B Mariani, Serena Ludovisi, Raffaella Lissandrin, Antonio Parisi, Paolo Sacchi, SFA Patruno, G Michelone, Roberto Gulminetti, Domenico Zanaboni, Stefano Novati, Renato Maserati, P Orsolini, Marco Vecchia, Marco Sciarra, Erika Asperges, Marta Colaneri, Di Filippo A, Margherita Sambo, Simona Biscarini, Matteo Lupi, Silvia Roda, T.C. Pieri, Ilaria Gallazzi, Michele Sachs, P. Valsecchi, Stefano Perlini, C Alfano, Marco Bonzano, Domenica Federica Briganti, Giuseppe Crescenzi, A.G. Falchi, Roberta Guarnone, Barbara Katia Guglielmana, Enrico Maggi, Ilaria Martino, Pietro Pettenazza, Serena Pioli di Marco, Francesca Maria Quaglia, Anna Sabena, Francesco Salinaro, Francesco Speciale, Ilaria Zunino, M De Lorenzo, Gioel Gabrio Secco, L. Dimitry, Giovanni Cappa, Igor Maisak, Benedetta Chiodi, M. Sciarrini, Bruno Barcella, Flavia Resta, Luca Moroni, Giulia Vezzoni, Lorenzo Scattaglia, Enrico Boscolo, Caterina Zattera, MF Tassi, Vincenzo Capozza, Damiano Vignaroli, Marco Bazzini, Giorgio Antonio Iotti, Francesco Mojoli, Mirko Belliato, Luciano Perotti, Silvia Mongodi, Guido Tavazzi, Gian Luigi Marseglia, Amelia Licari, Ilaria Brambilla, Daniela Barbarini, Antonio Bruno, Patrizia Cambieri, Giulia Campanini, C. Cavanna, Giuditta Comolli, Marta Corbella, R. Daturi, Milena Furione, B Mariani, P. Marone
Gianotti-Crosti syndrome: a study of 26 cases
Alain Taı̈eb, P. Plantin, Pierre Pasquier, G. Guillet, J Maleville
Autoantibodies and common viral illnesses
Karen E. Hansen, Jón Árnason, Alan J. Bridges
Where is Parvovirus B19 Infection Studies research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Parvovirus B19 Infection Studies is open access?
ScholarIQopen access share
33%OPEN ACCESS